Extended-release guaifenesin/pseudoephedrine hydrochloride for symptom relief in support of a ‘wait and see’ approach for the treatment of acute upper respiratory tract infections: A randomized, double-blind, placebo-controlled study

This study was not designed to assess the effects of guaifenesin or pseudoephedrine individually. Other limitations include the need for better clinical methods to assess the effectiveness of treatments for acute symptoms of patients with URTIs. Trial registration: ClinicalTrials.gov NCT01202279. Registered 13 September 2010.
Source: Current Therapeutic Research - Category: Drugs & Pharmacology Source Type: research